SCHEMBL16490261

SCHEMBL16490261

Nc1ccc2cc(S(=O)(=O)O)cc(O)c2c1/N=N/c1ccccc1S(=O)(=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 3/20 0.60
▸ CYP1A2 P05177 4/20 0.57
▸ APEX1 P27695 3/20 0.55
▸ SENP2 Q9HC62 4/20 0.54
▸ SUMO2 P61956 3/20 0.54
▸ SUMO1 P63165 3/20 0.54
▸ SENP7 Q9BQF6 3/20 0.54
▸ MAPK1 P28482 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ CYP2C9 P11712 2/20 0.48
▸ DNASE1L3 Q13609 1/20 0.48
▸ PHLPP2 Q6ZVD8 1/20 0.45
▸ PRMT1 Q99873 1/20 0.45
▸ HIF1A Q16665 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ PTPRA P18433 1/20 0.44
▸ PTPRB P23467 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ RAPGEF4 Q8WZA2 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14001583 1.00 ENPP2 (0.60) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL11226640 0.91 ENPP2 (0.67) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL11226638 0.91 ENPP2 (0.67) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL29533645 0.90 APEX1 (0.70) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL14133503 0.87 APEX1 (0.50) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL11339046 0.86 ENPP2 (0.61) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL11317617 0.85 ENPP2 (0.60) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL15113036 0.84 ENPP2 (0.54) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL7790539 0.83 SENP2 (0.68) ENPP2CYP1A2APEX1SENP2SUMO2
SCHEMBL7790541 0.83 SENP2 (0.68) ENPP2CYP1A2APEX1SENP2SUMO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364403-B2 Hair treatment methods PERACHEM LIMITED (GB) 2016-06-14 — — US disclosed
US-9320695-B2 Hair treatment methods PERACHEM LIMITED (GB) 2016-04-26 — — US disclosed
US-20150068548-A1 Hair Treatment Methods HSNF LIMITED (GB) 2015-03-12 — — US disclosed
US-20150047131-A1 Hair Treatment Methods HSNF LIMITED (GB) 2015-02-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150068548-A1 Hair Treatment Methods TST, OAT, SLC14A1 ENPP2 4286/4885CYP1A2 1824/4885APEX1 1758/4885
US-20150047131-A1 Hair Treatment Methods POLR1C, SHH, DNMT3A ENPP2 4483/4885CYP1A2 1803/4885APEX1 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback